简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-10-19 15:11 QuintilesIMS Wins Society for Clinical Research Sites’ 2016 Eagle Award
2016-10-19 10:01 Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th International Symposium on Hodgkin Lymphoma (ISHL)
2016-10-18 11:57 Oral Ozanimod Efficacy and Safety Results from Phase 2 TOUCHSTONE Extension Trial in Patients with Ulcerative Colitis to Be Presented at UEGW and ACG
2016-10-18 10:04 Mammoplasty Using Implants, Safety Must Come First! TL Plastic Surgery
2016-10-17 11:24 QuintilesIMS Named 2016 Frost & Sullivan Asia Pacific CRO Company of the Year
2016-10-17 10:11 Oral GED-0301 Phase 1b Results Show Clinical Remission and Endoscopic Response at Week 12 in Patients with Active Crohn’s Disease
2016-10-14 09:52 Celgene to Present New Data on Investigational Compounds at UEGW and ACG Congresses
2016-10-13 10:14 Zymergen Announces $130 Million in Series B Funding, Led by SoftBank
2016-10-12 11:21 Cardinal Health Expands in Asia
2016-10-11 15:21 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter®
2016-10-11 15:13 Kymab and EpimAb Biotherapeutics Announce Multi-Target, Bispecific Antibody Cross-Licensing Agreement
2016-10-11 11:40 CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times
2016-10-11 11:28 Replicor to Disclose Late Breaking HBV Clinical Data at AASLD 2016
2016-10-11 10:27 Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
2016-10-11 10:16 Durvalumab Shows Promising Preliminary Early Data in Lung and Head & Neck Cancers
2016-10-10 18:01 IncellDx’s Quantitative Immuno-Oncology Assay OncoTect iO Published in New Study
2016-10-10 14:26 PerkinElmer’s New QSight™ Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs
2016-10-10 13:19 QuintilesIMS: Merger Creates a Leading Global Integrated Information and Technology-Enabled Healthcare Service Provider
2016-10-10 11:49 Galderma Campaign “Proof in Real Life”: Patients Tell their Stories One Year Later
2016-10-10 11:26 Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO 2016

Business Wire Weibo

Press Releases

Latest Releases